» Articles » PMID: 10514402

Tryptase-chymase Double-positive Human Mast Cells Express the Eotaxin Receptor CCR3 and Are Attracted by CCR3-binding Chemokines

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 1999 Oct 9
PMID 10514402
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Eosinophils, basophils, and Th2 cells express the chemokine receptor CCR3, which binds eotaxin, RANTES, and some other chemokines. Using immunohistochemistry and flow cytometry, we demonstrate that CCR3 is also expressed by a variable proportion of human mast cells in gut, skin, and lung tissue. By contrast, with the same anti-CCR3 antibody (B711), CCR3 was poorly if at all detectable on human Th2 cells in vitro and in vivo. Eotaxin neither induced histamine release from purified human mast cells nor increased anti-IgE-stimulated histamine secretion. However, both eotaxin and RANTES elicited mast cell migration in vitro with a similar efficacy. High percentages of CCR3-expressing mast cells were present in the skin and in the intestinal submucosa; much lower percentages were found in the intestinal mucosa and in lung interstitium. Double immunostaining with anti-CCR3 and anti-chymase antibody showed that the vast majority of CCR3-expressing mast cells in the various tissues examined were tryptase-chymase double-positive. Therefore, tryptase-chymase double-positive mast cells express CCR3 and are attracted by CCR3-binding chemokines, eotaxin, and RANTES. Our findings indicate that these chemokines may play an important role in the differentiation and/or migration of this mast cell subset in connective tissues, as well as in sites of allergic inflammation.

Citing Articles

Type 2 hypersensitivity disorders, including systemic lupus erythematosus, Sjögren's syndrome, Graves' disease, myasthenia gravis, immune thrombocytopenia, autoimmune hemolytic anemia, dermatomyositis, and graft-versus-host disease, are....

Huang Y, Shih L, Hsieh T, Tsai K, Lu K, Liao M Virulence. 2024; 15(1):2404225.

PMID: 39267271 PMC: 11409508. DOI: 10.1080/21505594.2024.2404225.


Mechanistic Insights into Eosinophilic Esophagitis: Therapies Targeting Pathophysiological Mechanisms.

Massironi S, Mulinacci G, Gallo C, Elvevi A, Danese S, Invernizzi P Cells. 2023; 12(20).

PMID: 37887317 PMC: 10605530. DOI: 10.3390/cells12202473.


Cancer as a Dysfunctional Immune Disorder: Pro-Tumor TH1-like Immune Response and Anti-Tumor THαβ Immune Response Based on the Complete Updated Framework of Host Immunological Pathways.

Lee Y, Tsai K, Lu K, Shih L, Hu W Biomedicines. 2022; 10(10).

PMID: 36289759 PMC: 9599225. DOI: 10.3390/biomedicines10102497.


Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain?.

Jacobs I, Ceulemans M, Wauters L, Breynaert C, Vermeire S, Verstockt B Front Immunol. 2021; 12:754413.

PMID: 34737752 PMC: 8560962. DOI: 10.3389/fimmu.2021.754413.


Bioinformatic analysis of eosinophil activity and its implications for model and target species.

Jenvey C, Alenizi D, Almasi F, Cairns C, Holmes A, Sloan S Parasitology. 2019; 147(4):393-400.

PMID: 31839015 PMC: 7119366. DOI: 10.1017/S0031182019001768.


References
1.
Mantovani A, Allavena P, Vecchi A, Sozzani S . Chemokines and chemokine receptors during activation and deactivation of monocytes and dendritic cells and in amplification of Th1 versus Th2 responses. Int J Clin Lab Res. 1998; 28(2):77-82. DOI: 10.1007/s005990050023. View

2.
Irani A, Bradford T, Kepley C, Schechter N, Schwartz L . Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem. 1989; 37(10):1509-15. DOI: 10.1177/37.10.2674273. View

3.
Welle M . Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J Leukoc Biol. 1997; 61(3):233-45. DOI: 10.1002/jlb.61.3.233. View

4.
Caughey G, Viro N, Calonico L, McDonald D, Lazarus S, Gold W . Chymase and tryptase in dog mastocytoma cells: asynchronous expression as revealed by enzyme cytochemical staining. J Histochem Cytochem. 1988; 36(8):1053-60. DOI: 10.1177/36.8.3134486. View

5.
De Paulis A, Ciccarelli A, de Crescenzo G, Cirillo R, Patella V, Marone G . Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine. J Allergy Clin Immunol. 1996; 98(1):152-64. DOI: 10.1016/s0091-6749(96)70237-3. View